Table 2.
Comparison of respondent demographics of participants who submitted research suggestions that mapped to answered (N=95) compared with unanswered (N=328) summary questions
| Unanswered (%) | Answered (%) | P value | |||
| N | 328 | 78 | 95 | 22 | |
| Stakeholder group | <0.005* | ||||
| Spinal surgeons | 157 | 48 | 75 | 79 | |
| People with DCM and their supporters | 82 | 25 | 12 | 13 | |
| Other healthcare professionals | 89 | 27 | 8 | 8 | |
| Age (SD) | 47.9 | 11.7 | 46.4 | 11.68 | 0.25 |
| Male gender | 230 | 70 | 84 | 88 | <0.005 |
| Region | 0.4 | ||||
| USA | 62 | 19 | 14 | 15 | |
| UK | 43 | 13 | 13 | 14 | |
| Canada | 27 | 8 | 4 | 4 | |
| Europe | 82 | 25 | 21 | 22 | |
| South America | 14 | 4 | 8 | 8 | |
| Middle East | 10 | 3 | 5 | 5 | |
| Asia | 49 | 15 | 18 | 19 | |
| Australasia | 13 | 4 | 6 | 6 | |
| Africa | 28 | 9 | 6 | 6 | |
| From a high-activity, DCM research cluster | 109 | 33 | 23 | 24 | 0.12 |
| High-income country | 250 | 76 | 63 | 66 | 0.07 |
A high-activity DCM research cluster was defined from a prior coauthor network analysis—specifically DCM research activity clusters geographically to North America and East Asia (Japan, China and South Korea).
*Significance, p<0.05.
DCM, degenerative cervical myelopathy.